by Caroline Fife, M.D. | Jan 13, 2025 | Cellular / Tissue-Based Products, CTP / Skin Substitute Arrests
The CGS J15 Contractor Medical Directors have given me permission to share the slide deck that was presented on December 20th, which was a training session on the upcoming “skin sub” LCD. This PDF of the slide deck reviews the LCD requirements for the treatment of...
by Caroline Fife, M.D. | Jan 10, 2025 | Cellular / Tissue-Based Products, CTP / Skin Substitute Arrests
According to data obtained from SmartTrak Medical Device and Wound Market Intelligence, in the third quarter of 2024 (Q324), the US Skin Substitute / Cellular Tissue Product (CTP) market reached $1.75 BILLION. That figure is up 64.0% compared to the third quarter of...
by Caroline Fife, M.D. | Dec 30, 2024 | Cellular / Tissue-Based Products, CTP / Skin Substitute Arrests
According to data obtained from SmartTrak Medical Device and Wound Market Intelligence, in the fourth quarter of 2024 ( Q424), the US Cellular Tissue Product (CTP) / Skin Substitute market grew 64.0% over the third quarter of 2023 (Q323). Three market leaders combined...
by Caroline Fife, M.D. | Dec 20, 2024 | Cellular / Tissue-Based Products, CTP / Skin Substitutes
On December 10th, the Medicare Administrative Contactors (MACs) held a virtual Town Hall meeting to discuss Local Coverage Determination (LCD) for Skin Substitutes / Cellular Tissue Products that goes into effect on February 12, 2025. The MAC medical directors spent...
by Caroline Fife, M.D. | Dec 18, 2024 | Cellular / Tissue-Based Products, CTP / Skin Substitutes
The Department of Justice (DOJ) released its annual report on fraud and abuse for the 2023 fiscal year. The lengthy report includes one account related to CTPs/skin subs which I mentioned in a previous blog when it happened. A Beverly Hills, California, plastic...
by Caroline Fife, M.D. | Dec 16, 2024 | Cellular / Tissue-Based Products, CTP / Skin Substitutes
This email inquiry is from a real patient who is a retired nurse. I can answer some of her questions but not all of them, particularly the ones around when a patient might be required to sign an ABN for skin subs. I will post any helpful answers that you send...
by Caroline Fife, M.D. | Dec 13, 2024 | Cellular / Tissue-Based Products
CGS J15 Webinar on Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers Join the CGS Chief Medical Officer on Friday, December 20, 2024, from 10:00AM to 11:00AM Eastern Time to review the following...
by Caroline Fife, M.D. | Dec 12, 2024 | Cellular / Tissue-Based Products, CTP / Skin Substitutes
Health and Human Services (HHS) announced Active Work Plan items (e.g., OIG audits, evaluations, and inspections) that are underway or planned over the next 2 years. Investigations regarding various aspects of “skin substitute” use are on the list along with the...
by Caroline Fife, M.D. | Dec 2, 2024 | Cellular / Tissue-Based Products, CTP / Skin Substitutes
Recently someone passed on what a clinician had told them about the Cellular Tissue Products / Skin Substitutes that they were using. The clinician said they were not worried about being paid for a particular product because it had an established ASP (Average Sales...
by Caroline Fife, M.D. | Nov 25, 2024 | Cellular / Tissue-Based Products, CTP / Skin Substitutes, Health Information Technology and Wound Care
You should read the entire LCD, because there is a lot to unpack. I will tackle various topics over the next several weeks, but here’s the list of covered and not-covered CTPs/skin subs for diabetic foot ulcers (DFUs) and Venous Leg Ulcers (VLUs). When will the...
